Long-term antipsychotic monotherapy for schizophrenia: Disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study

Martin Dossenbach, Jan Pecenak, Agata Szulc, Victoria Irimia, Martin Anders, Dusanka Logozar-Perkovic, Dalia Peciukaitiene, Moshe Kotler, Anatoly B. Smulevich, Teena M. West, Amanda J. Lowry, Tamas Treuer

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term antipsychotic monotherapy for schizophrenia: Disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences